A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

Go Back to All Clinical Trials

A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults

Brief description of study

The purpose of this study is to learn whether psilocybin, a psychedelic compound, can be given safely to older adults. We want to understand how psilocybin affects the body and mind, including blood pressure, heart rhythm, and mood. We also want to see how the body processes psilocybin (how quickly it is absorbed and cleared) and whether it affects thinking, memory, or wellbeing.

Clinical Study Identifier: s25-01553

ClinicalTrials.gov Identifier: NCT07516405

Principal Investigator: Stephen Ross.

Other Investigators: Joshua Siegel, Daniel Edward Roberts, Petros Dimitrios Petridis, Kelley O'Donnell, Xiaojue Hu.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies